Fossen Jayce D, Gow Sheryl, Waldner Cheryl L
Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Canadian Integrated Program for Antimicrobial Resistance Surveillance, Public Health Agency of Canada, Saskatoon, SK, Canada.
Am J Vet Res. 2025 Apr 1;86(6). doi: 10.2460/ajvr.25.01.0021. Print 2025 Jun 1.
To examined potential risk factors for the frequency of antimicrobial use (AMU) within herd and potential associations between AMU and the frequency of antimicrobial resistance (AMR) in fecal organisms in beef calves.
In this observational study, all interested herds from the Canadian Cow-Calf Surveillance Network shared individual treatment records in 2021 for nursing calves (N = 56); a subset also provided fecal samples from calves in the spring and fall of 2021 (N = 31). Herd attributes were examined for associations with frequency of AMU. Associations were also estimated between frequency of AMU by drug class and subsequent frequency of AMR for Escherichia coli and Enterococcus spp in the spring and fall.
Individual animal AMU for nursing calves included oxytetracycline, florfenicol, and macrolides. Herds with at least 300 versus < 300 cows, that sold some seedstock compared to 100% commercial, and assisted more cows at calving reported more frequent AMU within herd. Antimicrobial use drug class and AMR class were not associated with E coli or Enterococcus spp recovered from calf fecal samples in the spring or fall of 2021, except for macrolide use and macrolide resistance in the fall for Enterococcus spp (OR, 1.54; 95% CI, 1.26 to 1.89 per 10% increase).
The frequency of AMU in nursing calves is relatively low in most herds. Antimicrobial use was not associated with AMR, with 1 exception. The availability of individual records and fecal samples limited statistical power.
Antimicrobial stewardship, including best practices for prescribing and administering antimicrobials, remains a priority for veterinarians and the beef industry.
研究牛群中抗菌药物使用(AMU)频率的潜在风险因素,以及AMU与肉牛犊粪便微生物中抗菌药物耐药性(AMR)频率之间的潜在关联。
在这项观察性研究中,加拿大奶牛-犊牛监测网络中所有感兴趣的牛群分享了2021年哺乳犊牛的个体治疗记录(N = 56);其中一个子集还提供了2021年春季和秋季犊牛的粪便样本(N = 31)。研究牛群属性与AMU频率之间的关联。还估计了按药物类别划分的AMU频率与春季和秋季大肠杆菌和肠球菌属后续AMR频率之间的关联。
哺乳犊牛的个体动物AMU包括土霉素、氟苯尼考和大环内酯类。与拥有不到300头奶牛的牛群相比,拥有至少300头奶牛的牛群、出售一些种畜而非100%商业化养殖的牛群以及在产犊时辅助更多奶牛的牛群,其牛群内AMU频率更高。2021年春季或秋季,从犊牛粪便样本中分离出的大肠杆菌或肠球菌属与抗菌药物使用类别和AMR类别无关,但秋季肠球菌属的大环内酯类使用与大环内酯类耐药性有关(比值比,1.54;95%置信区间,每增加10%为1.26至1.89)。
大多数牛群中哺乳犊牛的AMU频率相对较低。抗菌药物使用与AMR无关,仅有1个例外。个体记录和粪便样本的可得性限制了统计效力。
抗菌药物管理,包括抗菌药物处方和给药的最佳实践,仍然是兽医和牛肉行业的优先事项。